Does microdosing actually do anything, or is it a posh urban myth? A research team in New Zealand is about to find out in the world’s first randomized, controlled clinical trial.

LSD has largely been ignored while the world gushes over legal weed and decriminalized magic mushrooms. But a new research project in New Zealand will assess whether the counterculture’s favorite psychedelic is just a hedonistic substance or a tried-and-true medical treatment.The clinical trial, led by Dr. Suresh Muthukumaraswamy at the University of Auckland, will investigate whether LSD and psilocybin microdoses actually do anything, and if they do, whether those effects can translate to medical treatments.

“The data looks promising, but it’s not clear yet… whether the risk-benefit ratio is there, and we’re not sure yet whether it might work over and above a good placebo,” Muthukumaraswamy told the NZ Herald.

While you may have never heard of Muthukumaraswamy before, you’ve likely seen some of his research, especially if you’re a devoted acid head. In 2016, he was part of the research group that performed brain imaging studies on people tripping from LSD. The study discovered that LSD works by connecting all parts of the brain together at once. The findings were so mind-blowing that Inverse awarded the study “Experiment of the Year” and noted that it would “fundamentally alter the future of an entire field.”

LSD has made some serious strides over the decades, from Woodstockto modern medical clinics. Otherwise known as acid, LSD is known for causing hallucinations and fuzzy, feel-good thoughts, but it could also treat everything from PTSD to drug addiction to clinical depression. The same goes for psilocybin, the psychedelic component of “magic mushrooms.”

Read from original article

The World’s First Clinical Trials on Microdosing LSD and Psilocybin Are Coming

The World’s First Clinical Trials on Microdosing LSD and Psilocybin Are Coming